BICX - BioCorRx Inc.

0.49
0.178   36.327%

Share volume: 49
Last Updated: 04-09-2025
Healthcare/Services – Health: -0.01%

PREVIOUS CLOSE
CHG
CHG%
$0.31
0.18
0.57%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
33%
Profitability 25%
Dept financing 25%
Liquidity 0%
Performance 50%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
22.81%
3 Months
4.26%
6 Months
19.51%
1 Year
19.51%
2 Year
19.51%
Key data
Stock price
$0.49
P/E Ratio 
0.00
DAY RANGE
$0.46 - $0.49
EPS 
-$0.48
52 WEEK RANGE
$0.26 - $1.45
52 WEEK CHANGE
$19.51
MARKET CAP 
4.080 M
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$49
AVERAGE 30 VOLUME 
$4,295
Company detail
CEO:
Region: US
Website: biocorrx.com
Employees: 0
IPO year: 2014
Issue type:
Market: OTCM
Industry: Healthcare/Services – Health
Sector: Services

BioCorRx Inc. develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant. UnCraveRx also develops BICX101, an injectable product; and BICx104, an implantable implant for the treatment of opioid addiction and alcoholism.

Recent news
loading